Efficacy of Rituximab for Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis in Indonesian National Referral Hospital

被引：0
|
作者：
Siregar, Desmita [1 ]
Estiasari, Riwanti [2 ]
Imran, Darma [2 ]
Maharani, Kartika [2 ]
机构：
[1] Univ Indonesia, Dept Neurol, Fac Med, Depok, Indonesia
[2] Dr Cipto Mangukusumo Hosp, Jakarta, Indonesia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-56
引用
收藏
页码：NP22 / NP22
页数：1
相关论文
共 50 条
  • [31] Differential Brainstem Atrophy Patterns in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
    Lee, Chi-Yan
    Mak, Henry Ka-Fung
    Chiu, Pui-Wai
    Chang, Hing-Chiu
    Barkhof, Frederik
    Chan, Koon-Ho
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 47 (06) : 1601 - 1609
  • [32] Health utilities of patients with multiple sclerosis and neuromyelitis optica spectrum disorders in Thailand
    Siritho, Sasitorn
    Thavorncharoensap, Montarat
    Chanatittarat, Chalakorn
    Pasogpakdee, Pakamas
    Apiwattanakul, Metha
    Prayoonwiwat, Naraporn
    Chankrachang, Siwaporn
    Riewpaiboon, Arthorn
    Chaikledkaew, Usa
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 24 : 151 - 156
  • [33] Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
    Tetsuya Akaishi
    Toshiyuki Takahashi
    Tatsuro Misu
    Michiaki Abe
    Tadashi Ishii
    Juichi Fujimori
    Masashi Aoki
    Kazuo Fujihara
    Ichiro Nakashima
    Scientific Reports, 10
  • [34] Duration of B-cell depletion in patients receiving ocrelizumab or rituximab for Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorders
    AbdelRazek, M. A.
    Casasola, M.
    Mollashahi, R.
    Brodski, A.
    Morin, S.
    Augustynowicz, A.
    Jassim, S.
    Matiello, M.
    Sloane, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 100 - 100
  • [35] Personalized estimates of morphometric similarity in multiple sclerosis and neuromyelitis optica spectrum disorders
    Sun, Jie
    Zhao, Wenjin
    Xie, Yingying
    Zhou, Fuqing
    Wu, Lin
    Li, Yuxin
    Li, Haiqing
    Li, Yongmei
    Zeng, Chun
    Han, Xuemei
    Liu, Yaou
    Zhang, Ningnannan
    NEUROIMAGE-CLINICAL, 2023, 39
  • [36] Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
    Akaishi, Tetsuya
    Takahashi, Toshiyuki
    Misu, Tatsuro
    Abe, Michiaki
    Ishii, Tadashi
    Fujimori, Juichi
    Aoki, Masashi
    Fujihara, Kazuo
    Nakashima, Ichiro
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [37] Hospital Readmission Rates in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Patients
    Padarti, A.
    Amod, A.
    Kilgo, W. A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 64 - 65
  • [38] Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in caucasian patients
    Radaelli, M.
    Sangalli, F.
    Moiola, L.
    Rodegher, M.
    Colombo, B.
    Esposito, F.
    Fazio, R.
    Martinelli, V.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 351 - 351
  • [39] Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
    Radaelli, M.
    Moiola, L.
    Sangalli, F.
    Esposito, F.
    Barcella, V.
    Ferre, L.
    Rodegher, M.
    Colombo, B.
    Fazio, R.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 511 - 519
  • [40] Serious adverse events related to Rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder patients
    Ryerson, L. Zhovtis
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 935 - 936
12345